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A 17-month-old boy in India with severe acute respiratory 
infection was laboratory confirmed to have avian influenza 
A(H9N2) virus infection. Complete genome analysis of the 
strain indicated a mixed lineage of G1 and H7N3. The strain 
also was found to be susceptible to adamantanes and neur-
aminidase inhibitors.
Low-pathogenicity avian influenza A(H9N2) viruses have a wide host range, and outbreaks in poultry 
have been recorded since the 1990s in China (1). In In-
dia, avian specimens indicated no serologic evidence of 
H5N1 and H9N2 during 1958–1981 (2); however, 5%–
6% persons with direct exposure to poultry had H9N2 
antibodies (3). Human cases of influenza H9N2 virus in-
fection have been observed in Hong Kong, China, Ban-
gladesh, and Pakistan (4–7).
An institutional review board approved an ongoing 
community-based surveillance in 93 villages of Korku 
tribes in Melghat District, Maharashtra State, India, to de-
termine incidence of respiratory syncytial virus (RSV)–as-
sociated deaths among children <2 years of age. A total of 
2,085 nasopharyngeal swabs from children with severe or 
fatal pneumonia were transported to India’s National Insti-
tute of Virology to test for influenza, RSV, and other respi-
ratory viruses. A nasopharyngeal swab from a 17-month-
old boy received on February 12, 2019, tested positive by 
PCR for influenza A(H9N2) virus.
The child, a resident of Melghat, had fever, cough, 
breathlessness, and difficulty feeding for 2 days after 
illness onset on January 31, 2019. His high intermittent 
grade fever had no diurnal variation and no association 
with rash or mucocutaneous lesions. Examination re-
vealed a conscious, restless child with a respiratory rate 
of 48 breaths/min and lower chest wall in-drawing with 
intermittent absence of breathing for >20 seconds. He 
was fully immunized for his age, with bacillus Calmette–
Guérin, diphtheria, hepatitis B, poliovirus, and measles 
vaccines. Both length and weight for age were less than 
–3 SD. History of travel with his parents to a local reli-
gious gathering 1 week before symptom onset was elic-
ited. The father had similar symptoms on return from the 
gathering but could not undergo serologic testing because 
of his migrant work. No history of poultry exposure was 
elicited. The child received an antibacterial drug and anti-
pyretics and recovered uneventfully.
We tested the clinical sample using duplex real-time 
PCR for influenza A/B, H3N2, and 2009 pandemic H1N1 
viruses; RSV A/B; human metapneumovirus; parainfluenza 
virus types 1–4; rhinovirus; and adenovirus. The sample 
was strongly positive for influenza A virus (cycle thresh-
old value 20) but negative for seasonal influenza viruses 
and all respiratory viruses. Real-time PCR analysis for 
avian influenza viruses H5N1, H7N9, H10N8, and H9N2 
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revealed positivity for H9N2 virus (cycle threshold value 
for H9 was 25). We confirmed this result by sequencing the 
matrix (M) and hemagglutinin (HA) genes of the isolate, 
designated A/India/TCM2581/2019/(H9N2); the M gene 
(260 bp) had 97.27% nucleotide identity with A/chicken/
India/99321/2009(H9N2), and the HA gene (225,478 
bp) had 96.93% nucleotide identity with A/chicken/
India/12CL3074/2015(H9N2). 
We then generated whole-genome sequences by us-
ing the Miniseq NGS Platform (Illumina, https://www.
illumina.com) and a de novo assembly program (CLC Ge-
nomics Software 10.1.1 [8]). We used MEGA7 (https://
megasoftware.net) with a Tamura-Nei nucleotide substi-
tution model including 1,000 replicates bootstrap sup-
port (9) for evolutionary analysis of 8 genes of A/India/
TCM2581/2019/(H9N2) (submitted to GenBank under 
accession nos. MK673893–900). The HA, neuramini-
dase, and nucleoprotein gene phylogeny of A/India/TCM 
2581/2019/(H9N2) grouped with the dominant G1 lineage 
(h94.1.1) and clustered with poultry strains from India 
and human strains from Bangladesh (Figure). The M, non-
structural, polymerase basic 1, polymerase basic 2, and 
polymerase acidic genes were related to an H7N3 isolate 
from Pakistan (10) (Appendix Figure 1, https://wwwnc.
cdc.gov/EID/article/25/12/19-0636-App1.pdf). We con-
firmed that the A/India/TCM2581/2019(H9N2) strain had 
low pathogenicity, showing a KSKR/GLF amino acids mo-
tif at the cleavage site of HA (335-341 [H9 numbering]). 
We observed 6 potential glycosylation sites (11, 87, 123, 
280, 287, and 472 [H9 numbering]) and loss of 2 sites 
(208 and 218 [H9 numbering]) in the HA gene of A/India/
TCM2581/2019(H9N2) with respect to G1 viruses. 
The virus was susceptible to adamantanes with S31 
and to neuraminidase inhibitor with R292 and E119 (N2 
numbering) (11). A/India/TCM2581/2019(H9N2) had 
Q226L and I155T in HA gene, which promote the human 
receptor binding. Compared with G1 vaccine strain A/
Hong Kong/1073/99, the study strain had multiple mam-
malian-specific mutations that already exist in poultry-
adapted H9N2. The study strain had amino acid changes 
R207K, H436Y, and M677T in the polymerase basic 1 
gene; A515T in the polymerase acidic 1 gene; N30D, 
T215A, and T139A (all H3 numbering) in the matrix 1 
gene; and P42S in the nonstructural 1 gene, all of which 
are known to be associated with mammalian host speci-
ficity and increased virulence in ferrets and mice (12). 
Known markers for virulence and transmission (E627K 
and D701N) in the polymerase basic 2 gene in the study 
strain were absent (Appendix Table 1).
Bayesian evolutionary analyses using BEAST version 
1.8.1 (13) of the HA gene of H9N2 poultry strains from 
India indicated 3 clusters of multiple introductions at the 
estimated node age of 2000–2001 (Appendix Figure 2). 
Human strain A/India/TCM2581/2019(H9N2) and the 
other poultry viruses from India evolved with 5.163 × 10–3 
substitutions/site/year.
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Figure. Phylogenetic tree of hemagglutinin gene (A) and neuraminidase gene (B) gene of influenza virus A/India/TCM 2581/2019(H9N2) 
from India (black circle) and reference strains. The numbers above the branches are the bootstrap probabilities (%) for each branch, 
determined by using MEGA 7.0 (https://megasoftware.net). Human cases from other countries are in bold. Scale bars indicate 
nucleotide substitutions per site.
In conclusion, multiple introductions of H9N2 viruses 
in poultry have been observed in India. The identification 
of a human case of H9N2 virus infection highlights the im-
portance of systemic surveillance in humans and animals to 
monitor this threat to human health.
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